021-51111890
购物车（）
sales@molnova.cn
GRL-0496
CAS No. 1087243-14-8
GRL-0496 ( —— )
产品货号. M28825 CAS No. 1087243-14-8
GRL-0496 is a potent inhibitor with an enzyme inhibitory activity against SARS-CoV 3CLpro with an IC50 of 30 nM and antiviral potency with an EC50 value of 6.9 μM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥599 | 有现货 |
|
| 5MG | ￥988 | 有现货 |
|
| 10MG | ￥1604 | 有现货 |
|
| 25MG | ￥3686 | 有现货 |
|
| 50MG | ￥5443 | 有现货 |
|
| 100MG | ￥7744 | 有现货 |
|
| 500MG | ￥15552 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GRL-0496
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述GRL-0496 is a potent inhibitor with an enzyme inhibitory activity against SARS-CoV 3CLpro with an IC50 of 30 nM and antiviral potency with an EC50 value of 6.9 μM.
-
产品描述GRL-0496 is a potent inhibitor with an enzyme inhibitory activity against SARS-CoV 3CLpro with an IC50 of 30 nM and antiviral potency with an EC50 value of 6.9 μM.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Topo I;DPPH;Antioxidant
-
研究领域——
-
适应症——
化学信息
-
CAS Number1087243-14-8
-
分子量272.7
-
分子式C14H9ClN2O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(c1c(cc[nH]2)c2ccc1)Oc1cc(Cl)cnc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Preparative isolation of six anti-tumour biflavonoids from Selaginella doederleinii Hieron by high-speed counter-current chromatography.Phytochem Anal. 2014 Mar-Apr;25(2):127-33.
产品手册
关联产品
-
[Arg8]-Vasotocin TFA...
[Arg8]-Vasotocin (TFA) is a nonmammalian vertebrate neurohypophyseal peptide.
-
D-Saccharic acid pot...
D-Saccharic acid potassium salt is a compound formed from oxidizing sugars which can be used to test for the presence of hepatic enzyme induction. Studies indicate that D-glucuronolactone dehydrogenase oxidizes D-Saccharic acid potassium salt into D-glucaro-l4;63-dilactone.
-
TMN355
TMN355 is a potent chemical inhibitor of cyclophilin A and reduces foam cell formation and cytokine secretion,and is used for atherosclerosis. Silencing cyclophilin A in THP-1 cells and human monocytes using siRNA or chemical inhibitor, TMN355 resulted in decrease in lipid uptake by 65-75% even after exposure to oxidized LDL.
